Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT".
Journal Article (Letter)
Full Text
Duke Authors
Cited Authors
- Bohula, EA; Giugliano, RP; Cannon, CP; Zhou, J; Murphy, SA; White, J; Tershakovec, AM; Blazing, MA; Braunwald, E
Published Date
- March 29, 2016
Published In
Volume / Issue
- 133 / 13
Start / End Page
- e463 -
PubMed ID
- 27022050
Electronic International Standard Serial Number (EISSN)
- 1524-4539
Digital Object Identifier (DOI)
- 10.1161/CIRCULATIONAHA.116.020947
Language
- eng
Conference Location
- United States